Supreme Court: Marking a Document as an Exhibit Does Not Prove its Contents || Supreme Court: Unpaid Consideration Alone Does Not Invalidate a Sale Deed || Bombay HC: Questioning Other Varsities' Degrees Could Cause 'Anarchy and Chaos' in Education System || Allahabad High Court: Regularization Claim Survives Employee’s Death Through Legal Heirs || Allahabad HC: Advocates Failing AIBE Within 2 Years of Provisional Enrolment Can’t Continue Practice || Bombay High Court Directs BCI to Scrutinise and Clear Pending Law College Affiliation Approvals || J&K HC: Circulating WhatsApp Message on Local COVID Cases Does Not Attract Section 505 IPC || Supreme Court: Non-Signatory Can Be Bound By an Agreement if Involved in Performing the Contract || Supreme Court: 'Washed-Off Theory' Inapplicable in Assessing Employee Retention Suitability || SC Directs States/UTs to Grant Ex-Servicemen Quota to Cadets Disabled 40% or More in Training

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :